Kinnate Biopharma Inc. (KNTE)
NASDAQ: KNTE
· Real-Time Price · USD
2.65
-0.01 (-0.38%)
At close: Apr 02, 2024, 8:00 PM
Kinnate Biopharma Revenue
Kinnate Biopharma reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2023, Kinnate Biopharma generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
84
Market Cap
124.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |